Study finds previously unidentified genetic mutation in a small protein provides significant protection against Parkinson’s disease

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

Build­ing on its in­fec­tious dis­ease work in Covid-19, malar­ia and tu­ber­cu­lo­sis, BioN­Tech is now rolling out a Phase I/II test of a jab to pro­tect

Two new immunotherapy-chemotherapy options are now approved for patients with primary advanced or recurrent endometrial cancer, the FDA announced. On Monday, the agency approved the